Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
Extraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC) and can have a significant impact on patient morbidity and quality of life. We assessed the effect of adalimumab (ADA) therapy on the resolution of EIMs among patients with moderate to severe UC in clinical pra...
Hlavní autoři: | Travis, S, Feagan, B, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, A, Thakkar, R, Pappalardo, B, Petersson, J, Bereswill, M, Chen, N, Skup, M |
---|---|
Médium: | Journal article |
Vydáno: |
Oxford University Press
2017
|
Podobné jednotky
-
Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
Autor: Travis, S, a další
Vydáno: (2017) -
Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
Autor: Travis, S, a další
Vydáno: (2017) -
Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results From InspirADA.
Autor: Travis, S, a další
Vydáno: (2017) -
The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
Autor: Sandborn, W, a další
Vydáno: (2016) -
Does it all ADA up? Adalimumab for ulcerative colitis.
Autor: Travis, S
Vydáno: (2011)